About Kura Sushi USA, Inc. Kura Sushi USA, Inc. is a leading technology-enabled Japanese restaurant concept with 83 locations across 22 states and Washington DC. The Company offers guests a ...

Shares of sushi restaurant chain Kura Sushi (NASDAQ:KRUS) jumped 4.2% in the afternoon session after investors reacted to the company's ongoing expansion efforts, which included a new restaurant ...

Kura Oncology Inc. (NASDAQ:KURA) is one of the stocks that will double in 2026. On November 24, Barclays analyst Etzer Darout ...

An update from Kura Sushi, Inc. ( ($JP:2695) ) is now available. Kura Sushi, Inc. has announced a resolution to distribute dividends of surplus, ...

Kura Oncology's FDA-approved Komzifti and strong financials offer growth potential in the evolving AML market. Learn more ...

The FDA recently approved the first drug in a new class of leukemia medicines. Kura Oncology’s endeavor to follow that newly blazed regulatory trail is now infused with $330 million from a ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

On November 13, 2025, Kyowa Kirin and Kura Oncology announced that the FDA has granted full approval for KOMZIFTI (ziftomenib) as the first once-daily targeted therapy for adults with relapsed or ...

Whether it’s partnering up, axing assets (or staff), selling off programs or taking out loans, the prolonged bear market has forced biotechs to get creative in order to stay afloat. Now, Kura Oncology ...

Kura and partner Kyowa Kirin announced the Nov. 13 approval in a company statement, and CEO Troy Wilson described the ...